Edition:
India

Jubilant Life Sciences Ltd (JULS.BO)

JULS.BO on Bombay Stock Exchange

672.90INR
23 Jun 2017
Change (% chg)

Rs-15.60 (-2.27%)
Prev Close
Rs688.50
Open
Rs691.70
Day's High
Rs695.60
Day's Low
Rs668.20
Volume
76,293
Avg. Vol
91,999
52-wk High
Rs879.10
52-wk Low
Rs298.05

Select another date:

Thu, Jun 1 2017

BRIEF-Jubilant Life Sciences restarts operations at its Gajraula unit

* Says co restarts operations at its distillery unit at Gajraula from June 1, 2017

BRIEF-Jubilant Life Sciences increases price up to 15 pct for its vitamin B3

* Says price increase of up to 15% for its vitamin B3 (Niacin & Niacinamide) with immediate effect, for non-contract customers Source text for Eikon: Further company coverage:

BUZZ-India's Jubilant Life Sciences jumps on Q4 profit surge

** Shares of Jubilant Life Sciences Ltd rise as much as 12.8 pct to 762 rupees

BRIEF-India's Jubilant Life Sciences March-qtr profit surges

* March quarter consol total revenue from operations 16.41 billion rupees

BRIEF-Jubilant Life Sciences receives ANDA approval for Amlodipine, Olmesartan Medoxomil tablets

* Says Jubilant receives ANDA approval for Amlodipine and Olmesartan Medoxomil tablets

BRIEF-India's Jubilant Life Sciences to buy Triad Isotopes' radiopharmacy business

* Says Jubilant to acquire radiopharmacy business of Triad Isotopes

BRIEF-Jubilant life sciences issuance commercial papers

* Says issuance of commercial papers of INR 750 million Source text for Eikon: Further company coverage:

BRIEF-Jubilant Life Sciences gets ANDA approval for olmesartan medoxomil tablets

* Says Jubilant Life Sciences receives ANDA approval for olmesartan medoxomil tablets

BRIEF-Jubilant Life Sciences issues commercial papers worth 1 bln rupees

* Says issuance of commercial papers of INR 1 billion Source text: http://bit.ly/2nXMIZI Further company coverage:

BRIEF-Jubilant Life Sciences' generic drug gets FDA nod for osteoarthritis, rheumatoid arthritis

* Says Jubilant Life Sciences receives ANDA approval for Celecoxib capsules

Select another date:

More From Around the Web